Gossamer Bio Inc (NASDAQ:GOSS)
| 10.62 Delayed Data As of Nov 26 |  -0.63 / -5.60%Today’s Change | 7.04 Today|||52-Week Range 14.30 | +9.82% Year-to-Date |
Latest GOSS News | Press Releases
No recent news for Gossamer Bio Inc.
Today’s Trading
| Previous close | 11.25 |
| Today’s open | 11.04 |
| Day’s range | 10.48 - 11.08 |
| Volume | 15,061 |
| Average volume (3 months) | 514,439 |
| Market cap | $810.9M |
Data as of 12:59pm ET, 11/26/2021
Growth & Valuation
| Earnings growth (last year) | -7.84% |
| Earnings growth (this year) | +12.07% |
| Earnings growth (next 5 years) | +5.26% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNDXSyndax Pharmaceutica... | -0.31 | -1.84% |
| KDNYChinook Therapeutics... | -0.98 | -5.97% |
| ---- | ||
| KNSAKiniksa Pharmaceutic... | -0.43 | -3.54% |
Data as of 1:00pm ET, 11/26/2021
Financials
| Next reporting date | March 25, 2022 |
| EPS forecast (this quarter) | -$0.76 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$243.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
